Cryosurgery in Oncology and Tumor Management
Cryosurgery has emerged as an important minimally invasive technique in the management of certain tumors and precancerous conditions. By using extreme cold to destroy abnormal tissue, cryosurgery offers an alternative to conventional surgical excision, particularly for patients who may not tolerate extensive surgery.
The procedure involves the insertion of a cryoprobe into or near the tumor under imaging guidance such as ultrasound, CT scan, or MRI. Extremely low temperatures are then delivered, causing rapid freezing of cancerous cells. Ice crystal formation disrupts cellular structures, while damage to blood vessels deprives the tumor of oxygen, leading to cell death.
Cryosurgery has been applied in the treatment of prostate, liver, kidney, lung, and bone tumors. It is also used for certain skin cancers and precancerous lesions. One of the major advantages of cryosurgery is its precision, which allows targeted destruction of abnormal tissue while preserving surrounding healthy structures.
Recovery time is generally shorter compared to traditional surgery, and many procedures are performed on an outpatient basis. Patients may experience mild pain, swelling, or temporary discomfort following treatment.
Although cryosurgery is not suitable for all cancer types, it remains a valuable option within multidisciplinary oncology care, offering effective tumor control with reduced physical burden on patients.